Crossref
RAS and RAF mutation status in the selection of patients for anti-EGFR therapy
Colorectal Cancer · 2016
DOI: 10.2217/crc-2015-0013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Colorectal Cancer, 2016. Verfasst von Nuria Mulet-Margalef und 2 weiteren Autor:innen. Die Arbeit nennt 75 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Mulet-Margalef, N., Domènech, M., & Salazar, R. (2016). RAS and RAF mutation status in the selection of patients for anti-EGFR therapy. Colorectal Cancer. https://doi.org/10.2217/crc-2015-0013
Vancouver
Mulet-Margalef N, Domènech M, Salazar R. RAS and RAF mutation status in the selection of patients for anti-EGFR therapy. Colorectal Cancer. 2016. doi:10.2217/crc-2015-0013
BibTeX
@article{MuletMargalef2016,
author = {Mulet-Margalef, Nuria and Domènech, Marta and Salazar, Ramon},
title = {RAS and RAF mutation status in the selection of patients for anti-EGFR therapy},
journal = {Colorectal Cancer},
year = {2016},
doi = {10.2217/crc-2015-0013}
}
EUVIMED